Clinical Trials

HER2-positive Gastric Cancer

NCT05171166 2025-12-18

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

18 enrolled

Carcinoma, Hepatocellular

NCT06441565 2025-07-30

Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer

Phase 2/3 Recruiting

84 enrolled

Colorectal Neoplasms

NCT06280495 2025-05-30

Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients

Phase 2/3 Recruiting

156 enrolled

Phase 2/3 Active not recruiting

Colorectal Neoplasms

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

635 enrolled 9 charts

Colonic Neoplasms

NCT06028737 2025-05-06

OCTASUR

Phase 2/3 Recruiting

150 enrolled

Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms

NCT01249352 2025-03-31

NICE

104 enrolled

Phase 2/3 Active not recruiting

Adenocarcinoma, Esophageal Neoplasms

NCT01924819 2025-03-04

TOPGEAR

574 enrolled

Phase 2/3 Active not recruiting

Stomach Neoplasms

NCT02919787 2024-11-20

Nordic Pancreatic Cancer Trial (NorPACT) - 1

140 enrolled

Pancreatic Neoplasms

NCT03512756 2024-11-06

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

130 enrolled 13 charts

Phase 2/3 Not yet recruiting

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT06662877 2024-10-29

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

206 enrolled

Biliary Tract Neoplasms

NCT03607656 2023-12-18

CHANGE

270 enrolled

Stomach Neoplasms

NCT02661971 2022-07-11

RAMSES/FLOT7

180 enrolled

Stomach Neoplasms

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT04393584 2021-04-13

RusGCG-01

538 enrolled

Gastrointestinal Neoplasms, Stomach Neoplasms

NCT02172976 2020-09-02

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

40 enrolled

Pancreatic Neoplasms

NCT00952029 2020-03-30

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

492 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01216644 2019-06-19

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

716 enrolled

Pathologic Complete Response, Stomach Neoplasms

NCT02527772 2019-06-04

LD-FOX4/HCC

Carcinoma, Hepatocellular

NCT02534337 2019-06-04

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Carcinoma, Hepatocellular

NCT00647530 2019-05-17

FOxTROT

1,053 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT02220088 2019-01-11

The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial

79 enrolled

Carcinoma, Hepatocellular

NCT02767375 2017-08-10

HAICAT

192 enrolled

Carcinoma, Hepatocellular

NCT01646554 2017-05-09

BOS3

Colorectal Neoplasms

NCT00384176 2017-04-14

HORIZON III

1,814 enrolled 13 charts

Colorectal Neoplasms

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

4 enrolled

Esophageal Neoplasms

NCT01523431 2017-03-30

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

583 enrolled

Diarrhea, Neutropenia, Colorectal Neoplasms

NCT00861094 2015-12-18

Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer

266 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02529774 2015-08-20

Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer

432 enrolled

Resected Liver Metastases From Colorectal Cancer

NCT00735241 2015-05-22

FAST

Colonic Neoplasms, Colorectal Neoplasms

NCT01211210 2015-05-22

FOWARC

495 enrolled

Rectal Neoplasms

NCT01829178 2015-05-13

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

30 enrolled

Gastrointestinal Neoplasms

NCT02415699 2015-04-14

DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer

100 enrolled

Colorectal Neoplasms

NCT00785421 2015-01-08

PROSPECT

312 enrolled

Pancreatic Neoplasms

NCT00975897 2013-12-19

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

3,240 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00284258 2012-11-02

Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

426 enrolled

Colorectal Neoplasms

NCT00068744 2012-09-24

Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer

88 enrolled

Anus Neoplasms

NCT00960284 2012-01-13

PACT-7

102 enrolled

Pancreatic Neoplasms

NCT00274872 2010-02-01

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

600 enrolled